MEGAN FACKLER: Open Payments
NPI 1962897199 · NANCY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,551 in 77 payments from 15 companies in 2025. Trend: 2023 $2,491 · 2024 $761 · 2025 $1,551
Food & beverage: $1,451Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $351 |
| Janssen Biotech, Inc. | 12 | $304 |
| UCB, Inc. | 8 | $164 |
| Novartis Pharmaceuticals Corporation | 8 | $162 |
| AstraZeneca Pharmaceuticals LP | 8 | $158 |
| GlaxoSmithKline, LLC. | 7 | $139 |
| SOBI, INC | 3 | $56 |
| TerSera Therapeutics LLC | 1 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| PFIZER INC. | 2 | $29 |
Products named: TREMFYA, RINVOQ, Bimzelx, SAPHNELO, BENLYSTA, SKYRIZI, COSENTYX, Kineret.
Industry payments across KY — which companies pay providers there.
